Article
CSPG4P12 polymorphism served as a susceptibility marker for esophageal cancer in Chinese population.
BMC cancer - 14 Jun 2024
Xu Hongxue, Yang Zhenbang, Hu Wenqian, Zhou Xianlei, Zhang Zhi, Zhang Xuemei
Abstract excerpt
BACKGROUND: Chondroitin sulfate proteoglycan 4 pseudogene 12 (CSPG4P12) has been implicated in the pathogenesis of various cancers. This study aimed to evaluate the association of the CSPG4P12 polymorphism with esophageal squamous cell carcinoma (ESCA) risk and to explore the biological impact of CSPG4P12 expression on ESCA cell behavior. METHODS: A case-control study was conducted involving 480 ESCA patients and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
